Skip to main content
Premium Trial:

Request an Annual Quote

MiR Scientific MiR Sentinel

MiR Scientific said it has launched its prostate cancer test MiR Sentinel in the United States, Puerto Rico and select international markets. The urine-based test analyzes small non-coding RNA using a proprietary biostatistical algorithm to assess the risk of aggressive prostate cancer and aid in the clinical management of men 45 years of age or older.

The current test is a refined and clinically validated version based on the firm's comprehensive miR Sentinel PCC4 assay, which received FDA Breakthrough Device Designation in the third quarter of 2020, as well as its original three-test model described in a proof-of-concept publication the same year.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.